You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CGD

Showing 1 - 25 of 72
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Subjects With Chronic Granulomatous Disease (CGD)

Recruiting
  • Chronic Granulomatous Disease
  • Specimen Donation
  • Woburn, Massachusetts
    Sanguine BioSciences, Inc.
Jun 14, 2023

Chronic Granulomatous Disease, CGD Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (JSP191)

Recruiting
  • Chronic Granulomatous Disease
  • CGD
  • JSP191
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 5, 2023

Chronic Granulomatous Disease X-linked (X-CGD) Trial in Rome, Milan (Ibuprofen, Myelostim, Mozobil)

Recruiting
  • Chronic Granulomatous Disease X-linked (X-CGD)
  • Rome, Lazio, Italy
  • +1 more
Oct 27, 2022

Chronic Granulomatous Disease, Infection Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (gp91

Recruiting
  • Chronic Granulomatous Disease
  • Infection
  • gp91 Grans
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 26, 2022

Vitamin D3, Chronic-granulomatous Disease, BCG Trial in Shanghai (Vitamin D3, Traditional treatment of CGD and TB)

Recruiting
  • Vitamin D3
  • +2 more
  • Vitamin D3
  • Traditional treatment of CGD and TB
  • Shanghai, Shanghai, China
  • +1 more
Mar 21, 2022

Children Diagnosed With Chronic Granulomatous Disease

Not yet recruiting
  • CGD
  • DHR
  • (no location specified)
Sep 15, 2022

P47-Phox, Deficiency of Trial in London (Lentiviral vector transduced CD34+ cells)

Not yet recruiting
  • P47-Phox, Deficiency of
  • Lentiviral vector transduced CD34+ cells
  • London, United Kingdom
    Great Ormond Street Hospital
Aug 2, 2022

Atherosclerosis in CGD and Other Disorders of the Immune System

Completed
  • Atherosclerosis
  • Chronic Granulomatous Disease (CGD)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jul 26, 2021

    Hyper-Immunoglobulin E. Syndrome (HEIS), Chronic Granulomatous Disease (CGD) Trial run by the National Institute of Allergy and

    Not yet recruiting
    • Hyper-Immunoglobulin E. Syndrome (HEIS)
    • Chronic Granulomatous Disease (CGD)
    • Blister induction
    • Skin Biopsies
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 24, 2022

    Evaluation of Patients With Immune Function Abnormalities

    Recruiting
    • Chronic Granulomatous Disease (CGD)
    • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      Chronic Granulomatous Disease Trial run by the NIAID (Sirolimus, Cyclophosphamide, Alemtuzumab)

      Recruiting
      • Chronic Granulomatous Disease
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jul 23, 2022

      Participation in a Research Registry for Immune Disorders

      Recruiting
      • Primary Immunodeficiencies
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Apr 7, 2022

        Chronic Granulomatous Disease Trial in Nijmegen, Amsterdam (posaconazole (PSZ))

        Completed
        • Chronic Granulomatous Disease
        • posaconazole (PSZ)
        • Nijmegen, Gelderland, Netherlands
        • +1 more
        Nov 26, 2020

        X-Linked Chronic Granulomatous Disease Trial in London (X vivo gene therapy)

        Active, not recruiting
        • X-Linked Chronic Granulomatous Disease
        • X vivo gene therapy
        • London, United Kingdom
        • +1 more
        May 20, 2021

        Severe Combined Immunodeficiency (SCID), Immunodeficiency With Predominant T-cell Defect, Unspecified, Severe Chronic

        Enrolling by invitation
        • Severe Combined Immunodeficiency (SCID)
        • +8 more
        • CD3/CD19 negative allogeneic hematopoietic stem cells
        • Pittsburgh, Pennsylvania
          Children's Hospital of Pittsburgh of UPMC
        Dec 6, 2021

        Chronic Granulomatous Disease, Inflammatory Gastrointestinal Disease, Inflammatory Skin Disease Trial run by the NIAID (XELJANZ

        Enrolling by invitation
        • Chronic Granulomatous Disease
        • +3 more
        • XELJANZ (tofacitinib)
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 19, 2023

        Patients Treated for Chronic Granulomatous Disease Since January

        Completed
        • Chronic Granulomatous Disease
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Nov 1, 2022

          Chronic Granulomatous Disease-associated Colitis Trial run by the NIAID (OpenBiome FMT product FMP250)

          Recruiting
          • Chronic Granulomatous Disease-associated Colitis
          • OpenBiome FMT product FMP250
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Nov 19, 2022

          Chronic Granulomatous Disease Trial run by the NIAID (drug, biological, radiation)

          Terminated
          Has Results
          • Chronic Granulomatous Disease
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          Apr 30, 2020

          Chronic Granulomatous Diseases (CGD) and Liver Lesions Trial run by the NIAID (Cool-tip RF Ablation System)

          Withdrawn
          • Chronic Granulomatous Diseases (CGD) and Liver Lesions
          • Cool-tip RF Ablation System
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          Mar 24, 2020

          Chronic Granulomatous Disease Trial in Shenzhen (Infusion of lentiviral TYF-CGD-modified autologous stem cells)

          Unknown status
          • Chronic Granulomatous Disease
          • Infusion of lentiviral TYF-CGD-modified autologous stem cells
          • Shenzhen, Guangdong, China
            Shenzhen Geno-immune Medical Institute
          Sep 18, 2019

          Complex of Carnitine Orotate and Biphenyl Dimethyl Dicarboxylate

          Not yet recruiting
          • Chronic Viral Hepatitis B With Delta-Agent
            • Esik, Almaty Region, Kazakhstan
            • +6 more
            Oct 3, 2023

            Patients Treated for Chronic Granulomatous Disease Since 1995

            Enrolling by invitation
            • Granulomatous Disease, Chronic
              • Birmingham, Alabama
              • +43 more
              Sep 1, 2021

              Chronic Granulomatous Disease Trial in Moscow (Plerixafor, Gcsf)

              Unknown status
              • Chronic Granulomatous Disease
              • Moscow, Russian Federation
                Dmitry Rogachev National Research Center of Pediatric Hematology
              Sep 16, 2019

              Interferon-gamma 1-b on Cells of Innate Immune System:

              Completed
              • Chronic Granulomatous Disease
              • Interferon Gamma-1B
              • Aurora, Colorado
                University of Colorado Anschutz Medical Campus
              Jan 20, 2021